Skip to main content
Caplight Logo









Nerai Bioscience AG

Nerai Bioscience AG

Private
ZurichHealthcare & Life Scienceshttps://nerai.bio/

Last Round

Seed

May 1, 2025

Total Funding Raised

$4.5M

Momentum

Top 25%

of companies Caplight tracks

Company Overview

Nerai Bioscience AG is a biotechnology company that pioneers novel, highly personalized CRISPR proteins to deliver cures for genetic diseases.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Precision Medicine, Medical AI

Business Model

B2B

Customer Profile

Revenue Share, Services & Consulting, Government Contracts

AI Layer

Application

Keywords

genome editingCRISPRgene therapyAI drug discoveryrare disease therapyprotein engineeringprecision gene editinggenerative biologybespoke genome editorsdirected evolutionhigh-throughput screeningbiopharma partnershipsdrug discovery platformplatform licensing

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Nerai Bioscience AG Comparables

Compare Nerai Bioscience AG with similar companies based on industry and business-model similarity.

Nerai Bioscience AG comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Scribe Therapeutics
77%
Arbor Biotechnologies
77%
Mammoth Biosciences
77%

Nerai Bioscience AG Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
SeedMay 1, 2025

Key People

Founding team and executive leadership

Vincent Forster

CEO and co-founder

Founding Team

Nerai Bioscience AG Investors

Notable investors and investment history

Nerai Bioscience AG investors
InvestorRounds
Gebert Rüf StiftungSeed
KickfundSeed
Swiss National Science FoundationSeed
Venture KickSeed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jul 25, 2026

    Monthly visitors increased 285% MoM, reaching 335.

  • Jan 20, 2026

    Monthly visitors increased 61% MoM, reaching 2.4K.

Nerai Bioscience AG Filings

Explore SEC and related filing metadata, where available.

Nerai Bioscience AG filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Nerai Bioscience AG's valuation, stock price, and market status.

Is Nerai Bioscience AG a public or private company?

Nerai Bioscience AG is a private company.

What is the current stock price of Nerai Bioscience AG?

Nerai Bioscience AG is a private company with no public stock price. No recent secondary market data is available.

How much is Nerai Bioscience AG worth (valuation)?

Valuation information for Nerai Bioscience AG is not publicly available.

Can I buy Nerai Bioscience AG stock?

Nerai Bioscience AG shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Nerai Bioscience AG's last funding round?

Nerai Bioscience AG's most recent funding round was Seed on May 1, 2025.

Who are the main investors in Nerai Bioscience AG?

Key investors in Nerai Bioscience AG include Gebert Rüf Stiftung, Kickfund, Swiss National Science Foundation, Venture Kick.

Will Nerai Bioscience AG IPO soon?

No public IPO plans have been announced for Nerai Bioscience AG.

How can I track Nerai Bioscience AG secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Nerai Bioscience AG's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersZurich
Employee Range6
Year Founded2019
Last FundingMay 1, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?